|Title:||5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection|
|Abstract:||Disclosed are novel 5,11-dihydro-6H-dipyrido[3,2-b; 2',3'-e][1,4]diazepines. These are useful in the prevention or treatment of HIV infection.|
|Inventor(s):||Hargrave; Karl D. (Brookfield, CT), Proudfoot; John R. (Newtown, CT), Adams; Julian (Ridgefield, CT), Grozinger; Karl G. (Ridgefield, CT), Schmidt, deceased; Gunther (late of Munich, DE), Engel; Wolfhard (Biberach, DE), Trummlitz; Gunther (Warthausen, DE), Eberlein; Wolfgang (Biberach, DE)|
|Assignee:||Boehringer Ingelheim Pharmaceuticals, Inc. (Ridgefield, CT)|
Patent Claim Types:|
see list of patent claims
|Compound; Use; Composition;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||179||► subscribe|
|African Regional IP Organization (ARIPO)||189||► subscribe|
|African Regional IP Organization (ARIPO)||9000188||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.